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1. Introduction
Pressure ulcers are a complex, aetiologically multifactorial clinical
problem [1], that aﬀects approximately 1 in 20 community and 1 in 10
hospital patients [2]. Pressure ulcers are considered to be one of the ﬁve
most common causes of patient harm [3] that cost the NHS an esti-
mated £1214 – £40 234 to heal, per episode, depending on pressure
ulcer severity and patient health state [4]. Pressure ulcer prevalence is
considered a key indicator of care quality, patient safety, and a priority
for improvement [5]. Pressure ulcer prevention is a multidisciplinary
responsibility with nursing clinicians at the forefront of caregiving [6].
The National Institute for Health and Care Excellence (NICE) re-
commends the use of a validated assessment framework for pressure
ulcer prevention, assessment and management [7]. This guidance
identiﬁes ameliorative care pathways for skin care, mechanical loading
and equipment resource provision. Therefore, use of a risk assessment
tool can be considered as central to guiding pressure ulcer-related care
quality [8].
The Waterlow Pressure Ulcer Risk Assessment Tool (‘Waterlow’) [9]
was developed in 1985, for use in medical and surgical settings and is
thought to be the most commonly used pressure ulcer risk assessment
tool in the UK [10]. Waterlow is used as the tool of choice across the
organisation and ameliorative care protocols activate for all patients
with a Waterlow score 10 or above i.e. patients scored as being at risk of
pressure ulcer development [11]. As such, Waterlow outcome/score
informs decisions standardises care practices [12] as well as evidences
process [10] of pressure ulcer prevention and management [9]. Wa-
terlow can, therefore, profoundly inﬂuence clinicians' actions and how
pressure relieving equipment is prescribed [7].
1.1. Rationale
To meet the ever-more complex clinical needs of patients and the
challenge of the zero pressure ulcer agenda [13], the organisation's
assessment, prevention and management care practices were examined.
A Tissue Viability Nurse led review, of patient records and Root Cause
Analysis (RCA) investigating pressure ulcers acquired while in the or-
ganisations care, highlighted issues of:
• Waterlow completion accuracy;
• Isolated use of Waterlow;
• Waterlow score focused care planning;
• Insuﬃcient prevention care planning;
• Waterlow overestimating risk resulting in:
◦ Inappropriate equipment prescription;
◦ Excessive need for ongoing monitoring;
• Risk assessment nursing time when the patient is not professionally
judged at risk of pressure ulcer development.
1.2. Aims
To explore clinicians' experiences of pressure ulcer, assessment,
prevention, and management care practices within the organisation.
1.3. Ethical considerations
The work was deemed a service evaluation; it, therefore, did not
meet the requirements for formal ethical approval by the Health
Research Authority [14,15]. All policies and procedures surrounding
research governance and Good Clinical Practice (GCP) were adhered to.
1.4. Setting
The service evaluation took place in a Community Health Services
NHS Trust within the UK and is referred to as ‘the organisation’.
2. Methods
2.1. Terminology
The term ‘survey’ is used to denote the data collection method,
‘questionnaire’ is used to denote the structured series of written
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questions administered, i.e. the data collection instrument.
2.2. Construction of the questionnaire
The principles described by Dillman [16] were used to devise an
electronic survey that was formatted and hosted using an online survey
administration website. An anonymously completed, online, largely
qualitative questionnaire approach was used to provide the easiest ac-
cess to clinicians [16], facilitate an opportunity for openness through
anonymity [17] and to capture detailed response [18].
A panel of six expert healthcare professionals employed within the
organisation supported questionnaire development and its pilot. The
panel comprised of two Tissue Viability Clinical Nurse Specialist Leads,
a Tissue Viability Clinical Nurse Specialist, a Nurse Specialist, a
Research Manager, and a Research Governance specialist. Two of the
Clinical Specialists were Community Nurses within the organisation,
before undertaking their specialist roles, with one of them moving to
their specialist role approximately 1-year before becoming a panel
member.
The issues highlighted within in the Tissue Viability Nurse-led re-
view of patient records, and RCA's were used to ground questionnaire
development. Three drafts were produced, with each inﬂuenced by the
feedback from the previous version. Group consensus was used to es-
tablish face validity. A pilot of the questionnaire was then undertaken
to ensure that questions captured the experience of using Waterlow in
clinical practice. No amendments were required.
The ﬁnal version comprised nine questions and became the
Experiences of Using the Waterlow Pressure Ulcer Risk Assessment Tool
(EUWT-Q). No personally identiﬁable data were collected.
Demographic data identiﬁed professional role and length of time using
Waterlow. Questions were both open and closed, however, responses to
closed questions asked for response expansion, for example, question 8
asked, “Do you think the Waterlow Pressure Ulcer Risk Assessment Tool
eﬀectively guides care planning? Please explain”. The last question was
designed to elicit free expression by asking “Is there anything you
would like to add about your experience of using the Waterlow Pressure
Ulcer Risk Assessment Tool?”. This ﬁnal free text response aimed to
capitalise on respondents' natural tendency to consider previous an-
swers, encourage the candid expression of opinions not captured within
previous questions, and highlight issues of importance [17].
2.3. Participants
A Tissue Viability Clinical Nurse Specialist Lead identiﬁed a pur-
posive sample of 79 clinicians employed across the organisation in
varying roles, that were users of Waterlow within their daily clinical
practice. An organisational employed administrator facilitated all con-
tact with participants, no participant information was shared with the
researcher.
2.4. Data analysis
The analysis adhered to principles of an inductively informed the-
matic analysis [19,20]. Codes were ﬁrst identiﬁed within question-by-
question groups as direct semantic representations, either in vivo, i.e.
the code is a verbatim text extract or as a patterned observation, before
conceptually driven ideas and assumptions underpinning explicit con-
tent were identiﬁed. Initial codes were then temporarily disregarded;
the data were reread, interconnecting relationships across the dataset
were developed and ﬁrst impressions of themes encapsulating codes
established. Initial codes were then compared with secondary codes.
Overlapping codes were meaningfully grouped and merged to become
overarching concepts across the dataset and were identiﬁed as potential
theme code groupings. The potential themes code groupings were then
explored to identify consistent, inconsistent and divergent content and
that they captured the ‘essence’ of conceptual and explicit content
without being over complex or diverse [19,20]. Finally, the potential
themes code groupings were reﬁned, deﬁned as themes and supporting
verbatim extracts were identiﬁed.
3. Results
The EUWT-Q yielded rich descriptive responses that included both
paragraphical and short contributions. Two interrelated key themes
were identiﬁed reﬂect clinicians' experiences of using Waterlow.
3.1. Respondent characteristics
Of the 79 clinicians contacted, 59 completed the EUWT-Q (response
rate 74%). Of these, 64% (n= 38) were Community Nurses.
Respondents had a high-level of experience using Waterlow with the
majority (42% n=25) having used Waterlow for more than 16 years,
see Table 1. Clinicians Characteristic Proﬁle.
3.2. Key code
Direct quotation extracts are used to illustrate meaning. A key code
(Table 2) is used to help identify clinician characteristics. The code is
created using three components; a job role code; time using Waterlow;
and a unique identiﬁcation number. For example, clinician CN0562 is a
Community Nurse, that has used Waterlow 0–5 years and is uniquely
identiﬁed as number 62.
3.3. Themes
3.3.1. Conﬁdence in waterlow supporting clinical decision-making
A theme of Conﬁdence in Waterlow Supporting Clinical Decision
Making was prominently distinguishable across the dataset. For some,
Waterlow was perceived as a “good risk indicator” (CN1620) that
helpfully prompted and guided clinical considerations and was a “good
baseline tool” (NS0534) that alerted possible patient deterioration. In
contrast, for others, completion diﬃculties emerged. Clinicians ex-
pressed confusion with interpreting ‘grey areas’ and diﬃculties identi-
fying and classifying risk factors [9]. These diﬃculties were com-
pounded by the possibility that risk factors could be interpreted
diﬀerently within their own context, or, diﬀerently by diﬀerent clin-
icians and as such, had seemingly diminished clinical decision-making
conﬁdence as these clinicians explain:
Table 1
Clinicians characteristic proﬁle.
Job role Time Using Tool in Years Total %
0–5 6–10 11–15 16+
Community Nurses (CN) 5 7 6 20 38 64%
Nurse Specialists (NS) 1 0 1 2 4 7%
Allied Health Professionals (AH) 4 0 1 0 5 8%
Healthcare Support Worker (HS) 7 1 0 0 8 14%
Other Professions (OP) 0 1 0 3 4 7%
Total 17 9 8 25 59
Percent 29% 15% 14% 42% 100%
Table 2
Clinician characteristics identiﬁcation key code.
Job Role Time Using Waterlow
CN Community Nurse 05 0–5 years
NS Nurse Specialist 60 6–10 years
AH Allied Health Professionals 11 11–15 years
HS Healthcare Support Worker 16 16 + years
OP Other Professions
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“Some sections could be interpreted as ambiguous, it depends on the
clinician completing Waterlow as to how they interpret the particular box
- especially e.g. under organ failure” (OP1618).
“…it is open to individual interpretation and 2 nurses could assess the
same patient and arrive at 2 diﬀerent scores” (CN1645).
“Lots of phrases around the oﬃce by staﬀ saying '' would you score 'x' for
neurological? or would you class 'x' as an organ failure?” (CN6027).
The essence of Waterlow is to predict the risk of PU development
[9]. Clinicians considered Waterlow to overestimate risk, and trigger
unnecessary or inappropriate clinical facing time and equipment pre-
scription as these clinicians explain:
“…seeing the patient and then seeing their Waterlow score, sometimes do
not match up. The patient can be in fairly good health and mobile, yet
they can end up with a high Waterlow score meaning they require
equipment which isn't always necessary” (HS0549).
“…some patients score high but are fully mobile, but due to high
Waterlow score means we have to carry out a SSKINS on each visit
which for diabetics this is on a daily basis this can be quite pointless for
those patients that are obviously not at risk” (CN1615).
Waterlow was also considered a static tool that was insensitive to
health deterioration. Insensitivity was perceived to cause diﬃculties
with process documentation when a patient's health status had changed
and their Waterlow score remained static as these clinicians explain:
“…Chronic disease patients have high scores which do not increase sig-
niﬁcantly when their condition is deteriorating… if a patient has mild
oedema, they score the same as severe oedema as there is no variation in
scoring available… deterioration in clinical condition means… they need
a change in product, frequently would not see any change in the
Waterlow score to support this decision” (NS1658).
3.3.2. Defensively nursing
The use of Waterlow had seemingly aﬀected the socio-political
working culture. Fearful, self-protective care practices were perceived
to have evolved in response to organisational imposed ramiﬁcations,
should patients develop pressure ulcers. This was perceived to have
been compounded by a propensity for Waterlow to overestimate pres-
sure ulcer development risk for some patients. Organisational policy
was perceived to disempower and overrule clinical judgement, and a
pressure to prescribe pressure relieving equipment was reported. This,
therefore, had become associated with a working culture that imparted
clinical autonomy barriers and defensive patterns of patient care deci-
sion-making, where (some), “clinicians focus on the score rather than,
foremost, the needs of the patient” (NS1112) had become established.
Consequentially, higher-grade equipment was being prescribed, even
when the prescription was contradictory to professional judgement.
“It is used as an assessment tool to beat us with as the bar is set to low…
We used to use our clinical judgement when doing an assessment but now
are too worried about the blame culture that we put in equipment into
houses where the patients are fully mobile but have high Waterlow score”
(CN6040).
“…CCG attitude is geared to blame clinician whatever their choice re-
gardless of comorbid and frailty factors” (CN1637).
“… the zero PU agenda] created an environment of fear which has
created a need to over prescribe pressure preventative equipment to those
patients scoring high but who do not necessarily require the equipment.
This has become acceptable practice to prevent avoidable pressure da-
mage and not what may be best practice for the patient” (CN1635).
A deep frustration was revealed that exposed incongruence between
professional philosophy and the clinical actions taken. Clinicians were
aware their clinical strategies were counterintuitive and directly linked
to defensive nursing, thus they outright requested change:
“…the Waterlow Tool is dated and it is time to look at a tool that is based
on more up to date evidence in relation to risk factors. The Waterlow is
time-consuming, open to interpretation and does not reliably prioritise the
risk factors that are particular to that patient. I believe it is seen as a tick
box exercise, another template that HAS to be completed rather than a
tool to aid care planning” (NS1112)
“Please replace it as soon as possible” (NS1658).
4. Discussion
There is an implicit assumption, that regardless of clinical experi-
ence, clinicians will gather the same data, make similar patient care
judgements, and that patients with similar needs, follow similar care
pathways. It is, however, unreasonable to assume, an assessment out-
come will always concur a clinician's professional judgement [21] or,
that an assessment outcome replaces experienced clinical evaluation
[22]. In the widest sense, this is reﬂective of practice. Identiﬁcation of
patients who are at high risk of developing pressure ulcers is crucial for
determining eﬀective pressure relief management strategies [23,24],
and it is the assessment tool that provides the foundational evidence on
which to base and standardise these practices [25]. As such, pressure
risk assessment tools can be considered to require certain fundamental
characteristics. They should correctly identify risk, produce consistent
results regardless of the clinician assessing the patient [26] and should
appropriately, eﬀectively, and reliably direct pressure relieving equip-
ment resources [27]. It can, therefore, be argued, that clinicians need to
perceive the tool they use to assess, prevent, and manage pressure ul-
cers as valuable, appropriate, and eﬃcacious directing pressure re-
lieving equipment prescription. This is particularly important when
considering the inﬂuence of the pressure ulcer assessment tool on
patterns of care and pressure relieving equipment prescription. Yet,
there is no evidence that demonstrates pressure ulcer risk assessment
tools adequately identify risk, reduce pressure ulcer incidence or im-
prove patient outcomes [28–32]. As such, clinical judgementis con-
sidered superior to pressure ulcer a risk assessment tools for identifying
patients at risk of pressure ulcer development [28–32,34].
The ﬁndings of this work are supported by the literature that evi-
dence poor inter- and intrarater reliability [31,32], and poor predictive
validity of Waterlow [33,34]. These excerpts indicate these clinicians
feel little conﬁdence that the use of Waterlow is associated with care
practices that are reﬂective of patient need, or supports clinical deci-
sion-making. Thus, over-prescription of pressure relieving equipment
may have resulted in some patients receiving inappropriate equipment
prescription. DeForge et al. [35] similarly note, how at an organisa-
tional level, policy, compliance requirements, risk management ex-
pectations and resource pressure can constrain staﬀ and result in ten-
sions that challenge clinician autonomy.
It seems counter-intuitive, that an overprescription of pressure re-
lieving equipment, has not eradicated avoidable pressure ulcers. The
solution is, therefore, more complex than one of more pressure pre-
ventative resources.
5. Strengths and limitations
The EUWT-Q was designed to capture the lived experiences, use of
using Waterlow in Clinical practice within the organisation, rather than
test a generalisable hypothesis or theory. Therefore, questions were not
piloted beyond the Expert Healthcare Professional panel. The EUWT-Q
generated rich insight surrounding clinical practice using the organi-
sation's clinicians' own words and meanings. A response rate of 74%,
was achieved. Following conventional wisdom, this can be considered a
good response rate that procured good data quality [36] thus,
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establishes representativeness and supports the outcomes. The work has
provided deeper meaning and wider context to the Tissue Viability
Nurse led patient record and RCA reviews that underpin the rationale
for the current work. A note of caution is however due. The work was
undertaken speciﬁcally to inform the organisation, and its clinicians'
perceptions and experiences may not be reﬂective of other clinicians'
perceptions and experiences surrounding clinical practice using Wa-
terlow.
6. Conclusion
The knowledge produced by the current work has important im-
plications elucidating seemingly costly working practices. Costly in
terms of care practices that are not necessarily associated with appro-
priate pressure relieving equipment prescription and a diminishing of
workforce morale. The ﬁndings indicate a need for quality improve-
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